Aptar Digital Health’s HeroTracker Sense named Gold Winner in InnoPack 2022 China Award’s Patient Adherence category; HeroTracker Sense transforms standard metered dose inhaler into smart connected device to track, monitor disease management

Sample article from our Health Care Sector

January 24, 2023 (press release) –

The Innopack 2022 China Awards announced Aptar Digital Health’s HeroTracker® Sense as Gold Winner and Aptar CSP Technologies’ Activ-Blister™ Solutions as Silver Winner in their respective categories

Aptar Pharma is proud to have won two InnoPack 2022 China Awards recently, in recognition of our HeroTracker® Sense and Activ-Blister™ solutions.

 HeroTracker® Sense by Aptar Digital Health was announced Gold Winner in the InnoPack 2022 China Awards’ Patient Adherence category. HeroTracker® Sense is a novel digital respiratory health solution that transforms a standard metered dose inhaler (pMDI) into a smart connected healthcare device, allowing patients living with respiratory conditions to track and monitor their disease management.

“We are really pleased to receive this award. We see HeroTracker® Sense as a product for the future, and one that will demonstrate significant value, creating real world evidence that can aid the support of reimbursement models in numerous different markets,” said Sai Shankar, President, Aptar Digital Health.

Aptar CSP’s Activ-Blister™ solutions, which was named Silver Winner in the Market Potential category of the Innopack 2022 China Awards, offers a new way to address drug product stability concerns for oral solid doses and capsule-based dry powder inhalers, extending shelf life and ensuring the efficacy of the drug product. The technology embeds the company’s patented 3-Phase Activ-Polymer™ film into individual blister cavities to create a custom-formulated microclimate around each dose to meet specific drug long-term and in-use stability requirements while maintaining therapeutic efficacy. Outfitted blisters can adsorb tailored amounts of moisture, scavenge oxygen, odors, or VOCs, emit aromas, or provide a combination of active protection.

Badre Hammond, Vice-President, Commercial Operations and GM, APAC, Aptar CSP Technologies, said, “At Aptar CSP, we believe that innovation start with patients and consumers in mind. Activ-Blister™ solutions creates a microclimate within the headspace of each pill or tablet ensuring stable and efficacious treatment from R&D to the pharmacy shelf.”

InnoPack China, part of CPhI & P-MEC China, announced the winners of the Innopack China 2022 Awards on December 20, 2022. An official awards ceremony is planned to take place later in 2023.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order health care sector coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.